Publication | Closed Access

Docking of disordered independent molecules of novel crystal structure of (N-(4-methoxyphenyl)-2-(3-methyl-2-oxo-3,4-dihydroquinoxalin-1(2H)-yl)acetamide as anti-COVID-19 and anti-Alzheimer's disease. Crystal structure, HSA/DFT/XRD

Crystal StructureMedicinal ChemistryBiochemistryMedicineNatural SciencesPharmacologyStructure ElucidationProtein MisfoldingNovel Crystal StructureMolecular DockingStructural BiologyDrug DiscoveryDisordered Independent Molecules